| # | Title | Journal | Year | Citations |
|---|
| 1 | Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients | Breast Cancer Research | 2009 | 658 |
| 2 | FDG-PET/CT in re-staging of patients with lymphoma | European Journal of Nuclear Medicine and Molecular Imaging | 2004 | 226 |
| 3 | Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer | Annals of Oncology | 2002 | 207 |
| 4 | Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies | Breast Cancer Research and Treatment | 2009 | 198 |
| 5 | Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies | Seminars in Oncology | 2004 | 161 |
| 6 | Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines | Anti-Cancer Drugs | 1996 | 134 |
| 7 | Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients | Gynecologic Oncology | 2011 | 127 |
| 8 | Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status | Leukemia | 2006 | 86 |
| 9 | Phase I study with a weekly 1 h infusion of paclitaxel in heavily pretreated patients with metastatic breast and ovarian cancer | European Journal of Cancer | 1996 | 66 |
| 10 | Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP) | Annals of Oncology | 1997 | 65 |
| 11 | Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell Lines in vitro | European Journal of Cancer | 1995 | 55 |
| 12 | Toxicity and/or insufficient analgesia by opioid therapy: risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center | Supportive Care in Cancer | 2000 | 49 |
| 13 | Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma | Melanoma Research | 2005 | 43 |
| 14 | A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma | Cancer Immunology, Immunotherapy | 1989 | 42 |
| 15 | Differential Expression of Drug Resistance-Related Genes between Sensitive and Resistant Blasts in Acute Myeloid Leukemia | Acta Haematologica | 2007 | 38 |
| 16 | Carbamoylation of glutathione reductase by n,n-bis(2-chloroethyl)-n-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function | Biochemical Pharmacology | 1997 | 35 |
| 17 | Adriamycin stimulates only the iron ion-induced, NADPH-dependent microsomal alkane formation | Biochemical Pharmacology | 1982 | 32 |
| 18 | Lack of neuroprotection by an ACTH (4?9) analogue. A randomized trial in patients treated with vincristine for Hodgkin?s or non-Hodgkin?s lymphoma | Journal of Cancer Research and Clinical Oncology | 2004 | 31 |
| 19 | Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia | British Journal of Haematology | 1992 | 30 |
| 20 | Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study | Cancer Immunology, Immunotherapy | 1993 | 30 |
| 21 | 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus | European Journal of Cancer | 1994 | 28 |
| 22 | The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML — A comparative morphometric study on sequential trephine biopsies | Annals of Hematology | 1995 | 26 |
| 23 | Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system | Oncogene | 2002 | 24 |
| 24 | Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b | Investigational New Drugs | 1987 | 23 |
| 25 | Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb):a pilot phase I/II trial | Annals of Oncology | 2002 | 22 |
| 26 | Oxaliplatin-DNA adduct formation in white blood cells of cancer patients | British Journal of Cancer | 2008 | 22 |
| 27 | Marrow transplantation for pancytopenia in dyskeratosis congenita | Blut | 1985 | 21 |
| 28 | Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia | Blut | 1987 | 21 |
| 29 | Apoptotic Genes in Cancer Therapy | Cells Tissues Organs | 2002 | 21 |
| 30 | Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines | British Journal of Cancer | 1996 | 20 |
| 31 | Commitment to differentiation of human promyelocytic leukemia cells (HL60): An all-or-none event preceded by reversible losses of self-renewal potential | Journal of Cellular Physiology | 1985 | 18 |
| 32 | Improving the biosafety of cell sorting by adaptation of a cell sorting system to a biosafety cabinet | Cytometry Part A: the Journal of the International Society for Analytical Cytology | 2005 | 18 |
| 33 | Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases | Oncology Reports | 2006 | 18 |
| 34 | Dissociation and isolation of antigen and antibody from immune complexes | Journal of Immunological Methods | 1982 | 17 |
| 35 | Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myeloma | Leukemia | 1998 | 17 |
| 36 | Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors | Critical Reviews in Oncology/Hematology | 2006 | 17 |
| 37 | Development and mechanisms of interferon resistance | Cancer Treatment Reviews | 1990 | 13 |
| 38 | The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP) | Lung Cancer | 2012 | 13 |
| 39 | Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation | European Journal of Cancer | 2013 | 13 |
| 40 | Primary gastric non-Hodgkin's lymphoma: a clinicopathological study of 41 patients | Journal of Cancer Research and Clinical Oncology | 1995 | 12 |
| 41 | Down-regulation of topoisomerase II by camptothecin does not prevent additive activity of the topoisomerase II inhibitor etoposide in vitro | Anti-Cancer Drugs | 1997 | 12 |
| 42 | Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea | Supportive Care in Cancer | 1997 | 12 |
| 43 | Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants | Experimental Hematology | 2003 | 12 |
| 44 | Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours | Medical Oncology | 1998 | 12 |
| 45 | Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study | Annals of Oncology | 1998 | 11 |
| 46 | Sister chromatid differentiation and cell-cycle-specific patterns in chronic myelocytic leukemia and normal bone marrow | International Journal of Cancer | 1982 | 10 |
| 47 | Changes in self-renewal potential of human leukemic cells (K562): A bidirectional stochastic process | Journal of Cellular Physiology | 1985 | 10 |
| 48 | Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas | Annals of Oncology | 1991 | 10 |
| 49 | Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer | Anti-Cancer Drugs | 1998 | 10 |
| 50 | Quantitation of immune complexes by nephelometry | Journal of Immunological Methods | 1979 | 9 |
